Aktien-Chart
Tickersymbol: GLTO Börsenplatz: NSM


Loading...
Kauf Verkauf Geplanter Kauf Geplanter Verkauf Netto-Kauf Netto-Verkauf Earnings
Earnings
 
Value bought

Letzte 90 Tage

 
Value sold

Letzte 90 Tage

 
Net insiders buying

Letzte 90 Tage

 
Trades (buy and sell)

Letzte 90 Tage

Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
Datum der Benachrichtigung Datum der Transaktion K/V Art der Transaktion Insider und/oder position Anz. der Aktien
Kurs
Wert
Anzahl der Aktien Kurs Wert Details
2025-01-07 2025-01-03 V Verkauf

Firmani Lori

Interim CFO

Führungsperson
261 -36.0%
5,63
1.469 USD
261 -36.0% 5,63 1.469 USD
2025-01-07 2025-01-03 V Verkauf

Schambye Hans T.

Chief Executive Officer

Geschäftsführender Verwaltungsratsmitglied
1.341 -28.3%
5,60
7.510 USD
1.341 -28.3% 5,60 7.510 USD
2025-01-07 2025-01-03 V Verkauf

Winslow Garrett

General Counsel

Führungsperson
471 -31.8%
5,60
2.638 USD
471 -31.8% 5,60 2.638 USD
2023-08-17 2023-08-15 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
535.534 -26.2%
0,75
401.651 USD
535.534 -26.2% 0,75 401.651 USD
2023-08-17 2023-08-15 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
248.819 -28.3%
0,75
186.614 USD
248.819 -28.3% 0,75 186.614 USD
2023-08-17 2023-08-15 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
38.327 -28.3%
0,75
28.745 USD
38.327 -28.3% 0,75 28.745 USD
2023-08-02 2023-07-31 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
153.078 -6.8%
3,00
459.234 USD
153.078 -6.8% 3,00 459.234 USD
2023-08-02 2023-07-31 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
29.700 -3.3%
3,00
89.100 USD
29.700 -3.3% 3,00 89.100 USD
2023-08-02 2023-07-31 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
26.622 -16.4%
3,00
79.866 USD
26.622 -16.4% 3,00 79.866 USD
2023-07-27 2023-07-25 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
26.700 -1.2%
2,92
77.964 USD
26.700 -1.2% 2,92 77.964 USD
2023-07-27 2023-07-25 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
4.700 -0.5%
2,92
13.724 USD
4.700 -0.5% 2,92 13.724 USD
2023-07-27 2023-07-25 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
7.800 -4.6%
2,92
22.776 USD
7.800 -4.6% 2,92 22.776 USD
2023-07-17 2023-07-13 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
132.100 -5.5%
2,40
317.040 USD
132.100 -5.5% 2,40 317.040 USD
2023-07-17 2023-07-13 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
52.800 -5.5%
2,40
126.720 USD
52.800 -5.5% 2,40 126.720 USD
2023-07-17 2023-07-13 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
9.800 -5.5%
2,40
23.520 USD
9.800 -5.5% 2,40 23.520 USD
2023-04-17 2023-04-17 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
8.878 -0.4%
1,97
17.490 USD
8.878 -0.4% 1,97 17.490 USD
2023-04-17 2023-04-17 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
3.551 -0.4%
1,97
6.995 USD
3.551 -0.4% 1,97 6.995 USD
2023-04-17 2023-04-17 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
660 -0.4%
1,97
1.300 USD
660 -0.4% 1,97 1.300 USD
2023-04-17 2023-04-14 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
28.110 -1.1%
1,86
52.285 USD
28.110 -1.1% 1,86 52.285 USD
2023-04-17 2023-04-14 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
11.245 -1.1%
1,86
20.916 USD
11.245 -1.1% 1,86 20.916 USD
2023-04-17 2023-04-14 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
2.091 -1.1%
1,86
3.889 USD
2.091 -1.1% 1,86 3.889 USD
2023-04-17 2023-04-13 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
9.459 -0.4%
1,82
17.215 USD
9.459 -0.4% 1,82 17.215 USD
2023-04-17 2023-04-13 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
3.784 -0.4%
1,82
6.887 USD
3.784 -0.4% 1,82 6.887 USD
2023-04-17 2023-04-13 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
703 -0.4%
1,82
1.279 USD
703 -0.4% 1,82 1.279 USD
2023-04-12 2023-04-12 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
1.603 -0.1%
1,81
2.901 USD
1.603 -0.1% 1,81 2.901 USD
2023-04-12 2023-04-12 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
641 -0.1%
1,81
1.160 USD
641 -0.1% 1,81 1.160 USD
2023-04-12 2023-04-12 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
119 -0.1%
1,81
215 USD
119 -0.1% 1,81 215 USD
2023-04-12 2023-04-11 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
9.459 -0.4%
1,82
17.215 USD
9.459 -0.4% 1,82 17.215 USD
2023-04-12 2023-04-11 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
3.784 -0.4%
1,82
6.887 USD
3.784 -0.4% 1,82 6.887 USD
2023-04-12 2023-04-11 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
703 -0.4%
1,82
1.279 USD
703 -0.4% 1,82 1.279 USD
2023-04-12 2023-04-10 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
34.745 -1.4%
1,79
62.194 USD
34.745 -1.4% 1,79 62.194 USD
2023-04-12 2023-04-10 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
13.899 -1.4%
1,79
24.879 USD
13.899 -1.4% 1,79 24.879 USD
2023-04-12 2023-04-10 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
2.584 -1.4%
1,79
4.625 USD
2.584 -1.4% 1,79 4.625 USD
2023-04-07 2023-04-06 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
6.558 -0.3%
2,00
13.116 USD
6.558 -0.3% 2,00 13.116 USD
2023-04-07 2023-04-06 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
2.620 -0.3%
2,00
5.240 USD
2.620 -0.3% 2,00 5.240 USD
2023-04-07 2023-04-06 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
487 -0.3%
2,00
974 USD
487 -0.3% 2,00 974 USD
2023-04-07 2023-04-05 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
63.058 -2.4%
2,18
137.466 USD
63.058 -2.4% 2,18 137.466 USD
2023-04-07 2023-04-05 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
25.220 -2.4%
2,18
54.980 USD
25.220 -2.4% 2,18 54.980 USD
2023-04-07 2023-04-05 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
4.687 -2.4%
2,18
10.218 USD
4.687 -2.4% 2,18 10.218 USD
2022-03-23 2022-03-22 K Kauf

Schambye Hans T.

Chief Executive Officer

Geschäftsführender Verwaltungsratsmitglied
5.000 +10.5%
2,15
10.750 USD
5.000 +10.5% 2,15 10.750 USD
2022-03-23 2022-03-22 K Kauf

Lindmark Bertil

Chief Medical Officer

Führungsperson
14.604 +730.2%
2,16
31.545 USD
14.604 +730.2% 2,16 31.545 USD
2021-12-06 2021-12-03 K Kauf

Freve Jonathan

Chief Financial Officer

Führungsperson
4.000 +50.0%
2,49
9.960 USD
4.000 +50.0% 2,49 9.960 USD
2021-12-06 2021-12-03 K Kauf

Winslow Garrett

General Counsel

Führungsperson
2.000 +100.0%
2,48
4.960 USD
2.000 +100.0% 2,48 4.960 USD
2021-11-10 2021-11-09 K Kauf

Schambye Hans T.

Chief Executive Officer

Geschäftsführender Verwaltungsratsmitglied
4.500 +10.5%
3,50
15.750 USD
4.500 +10.5% 3,50 15.750 USD
2021-11-09 2021-11-08 K Kauf

Freve Jonathan

Chief Financial Officer

Führungsperson
3.000 +60.0%
3,40
10.200 USD
3.000 +60.0% 3,40 10.200 USD
2021-06-28 2021-06-28 K Kauf

Lindmark Bertil

Chief Medical Officer

Führungsperson
2.000 +inf%
5,26
10.520 USD
2.000 +inf% 5,26 10.520 USD
2021-06-24 2021-06-24 K Kauf

Schambye Hans T.

Chief Executive Officer

Geschäftsführender Verwaltungsratsmitglied
3.000 +7.5%
5,11
15.330 USD
3.000 +7.5% 5,11 15.330 USD
2020-11-04 2020-11-02 K Kauf

Novo Holdings A/S

Large shareholder
333.333 +15.4%
15,00
4.999.995 USD
333.333 +15.4% 15,00 4.999.995 USD
2020-11-04 2020-11-02 K Kauf

Khuong Chau Quang

Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder
209.500 +25.5%
15,00
3.142.500 USD
209.500 +25.5% 15,00 3.142.500 USD
2020-11-04 2020-11-02 K Kauf

Khuong Chau Quang

Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder
523.833 +25.5%
15,00
7.857.495 USD
523.833 +25.5% 15,00 7.857.495 USD
2020-11-04 2020-11-02 K Kauf

Christgau Stephan

Nicht geschäftsführender Verwaltungsratsmitglied
66.666 +13.9%
15,00
999.990 USD
66.666 +13.9% 15,00 999.990 USD
2020-11-04 2020-11-02 K Kauf

ORBIMED ADVISORS LLC

Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder
209.500 +25.5%
15,00
3.142.500 USD
209.500 +25.5% 15,00 3.142.500 USD
2020-11-04 2020-11-02 K Kauf

ORBIMED ADVISORS LLC

Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder
523.833 +25.5%
15,00
7.857.495 USD
523.833 +25.5% 15,00 7.857.495 USD
// ... existing code ... // ... rest of the file ...